
    
      OUTLINE: Patients are randomized to 1 of 2 arms.

      ARM I: Patients undergo acupuncture therapy and receive BCG via intravesical injection on
      days 1, 8, 15, 22, 29, and 36 in the absence of unacceptable toxicity. Patients also receive
      standard of care symptom management.

      ARM II: Patients receive BCG via intravesical injection on days 1, 8, 15, 22, 29, and 36 in
      the absence of unacceptable toxicity. Patients also receive standard of care symptom
      management. Patients may undergo acupuncture therapy after completion of intravesical BCG
      therapy.

      After completion of study, patients are followed up at 1 week.
    
  